Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
21 03 2022
Historique:
accepted: 25 01 2022
received: 08 01 2022
pubmed: 13 2 2022
medline: 16 4 2022
entrez: 12 2 2022
Statut: ppublish

Résumé

In leiomyosarcoma class IIa HDACs (histone deacetylases) bind MEF2 and convert these transcription factors into repressors to sustain proliferation. Disruption of this complex with small molecules should antagonize cancer growth. NKL54, a PAOA (pimeloylanilide o-aminoanilide) derivative, binds a hydrophobic groove of MEF2, which is used as a docking site by class IIa HDACs. However, NKL54 could also act as HDAC inhibitor (HDACI). Therefore, it is unclear which activity is predominant. Here, we show that NKL54 and similar derivatives are unable to release MEF2 from binding to class IIa HDACs. Comparative transcriptomic analysis classifies these molecules as HDACIs strongly related to SAHA/vorinostat. Low expressed genes are upregulated by HDACIs, while abundant genes are repressed. This transcriptional resetting correlates with a reorganization of H3K27 acetylation around the transcription start site (TSS). Among the upregulated genes there are several BH3-only family members, thus explaining the induction of apoptosis. Moreover, NKL54 triggers the upregulation of MEF2 and the downregulation of class IIa HDACs. NKL54 also increases the binding of MEF2D to promoters of genes that are upregulated after treatment. In summary, although NKL54 cannot outcompete MEF2 from binding to class IIa HDACs, it supports MEF2-dependent transcription through several actions, including potentiation of chromatin binding.

Identifiants

pubmed: 35150567
pii: 6527676
doi: 10.1093/nar/gkac081
pmc: PMC8934631
doi:

Substances chimiques

Histone Deacetylase Inhibitors 0
MEF2 Transcription Factors 0
Vorinostat 58IFB293JI
Histone Deacetylases EC 3.5.1.98

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2566-2586

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Cell Rep. 2015 Nov 17;13(7):1444-1455
pubmed: 26549458
Cell Death Dis. 2013 Feb 28;4:e519
pubmed: 23449455
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Curr Opin Biotechnol. 2015 Dec;35:78-85
pubmed: 25935873
Eur J Med Chem. 2021 Feb 5;211:113015
pubmed: 33423841
PLoS Genet. 2017 Apr 18;13(4):e1006752
pubmed: 28419090
Toxicol Appl Pharmacol. 2016 Sep 1;306:69-78
pubmed: 27381264
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
JCI Insight. 2017 Sep 7;2(17):
pubmed: 28878124
Nat Genet. 2019 Dec;51(12):1714-1722
pubmed: 31784732
Genome Res. 2014 Aug;24(8):1271-84
pubmed: 24732587
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17335-40
pubmed: 17956988
Redox Biol. 2019 Jan;20:60-67
pubmed: 30292946
J Chem Inf Model. 2009 Jan;49(1):84-96
pubmed: 19125657
Nucleic Acids Res. 2021 Nov 8;49(19):10931-10955
pubmed: 34570228
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Biochem Soc Trans. 2016 Aug 15;44(4):979-86
pubmed: 27528742
Nature. 1997 Apr 3;386(6624):517-21
pubmed: 9087414
Mol Neurobiol. 2020 Nov;57(11):4549-4562
pubmed: 32757160
Genome Biol. 2014;15(12):550
pubmed: 25516281
PLoS One. 2016 May 12;11(5):e0155183
pubmed: 27171006
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
J Biol Chem. 2008 Dec 19;283(51):35402-9
pubmed: 18953021
PLoS Comput Biol. 2020 Feb 25;16(2):e1007664
pubmed: 32097405
J Med Chem. 2005 Jan 13;48(1):200-12
pubmed: 15634014
J Comput Aided Mol Des. 2019 Sep;33(9):855-864
pubmed: 31595406
Sci Rep. 2017 Jun 30;7(1):4476
pubmed: 28667250
Oncogene. 2017 Mar 23;36(12):1707-1720
pubmed: 27694895
Cancer Cell. 2017 Jul 10;32(1):27-41.e4
pubmed: 28625481
J Mol Cell Cardiol. 2020 Aug;145:88-98
pubmed: 32485181
Mol Oncol. 2019 Aug;13(8):1651-1668
pubmed: 31081251
J Mol Med (Berl). 2013 Jan;91(1):49-58
pubmed: 22763818
Oncogene. 2013 Jun 6;32(23):2828-35
pubmed: 23435418
Mol Biol Cell. 2004 Jun;15(6):2804-18
pubmed: 15075374
Curr Opin Neurobiol. 2019 Dec;59:49-58
pubmed: 31129473
FASEB J. 2013 Mar;27(3):942-54
pubmed: 23159930
Epigenetics Chromatin. 2016 Apr 16;9:15
pubmed: 27087856
Mol Cell Biol. 2015 May;35(9):1633-47
pubmed: 25733682
Oncotarget. 2016 Jan 19;7(3):2297-312
pubmed: 26506234
Curr Opin Oncol. 2019 Jul;31(4):317-321
pubmed: 31033567
Mol Cell Biol. 2007 Feb;27(4):1280-95
pubmed: 17158926
Clin Cancer Res. 2016 Jul 15;22(14):3560-70
pubmed: 26920892
J Biol Chem. 2008 Sep 26;283(39):26694-704
pubmed: 18614528
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
J Med Chem. 2015 Feb 26;58(4):1691-704
pubmed: 25639862
Epigenomics. 2016 Feb;8(2):251-69
pubmed: 26791815
Cell Mol Life Sci. 2015 Jan;72(1):73-86
pubmed: 25189628
Nucleic Acids Res. 2018 Dec 14;46(22):11776-11788
pubmed: 30321390
Cancers (Basel). 2021 May 13;13(10):
pubmed: 34068344
Nature. 2003 Apr 17;422(6933):730-4
pubmed: 12700764
Eur J Pharmacol. 2006 Nov 7;549(1-3):9-18
pubmed: 16978604
Mol Cancer Ther. 2021 Jun;20(6):1039-1051
pubmed: 33785653
Nature. 2015 Feb 5;518(7537):125-6
pubmed: 25653001
J Mol Biol. 2005 Jan 7;345(1):91-102
pubmed: 15567413
Life (Basel). 2021 Jan 27;11(2):
pubmed: 33513699
Nat Chem Biol. 2013 May;9(5):319-25
pubmed: 23524983
Oncotarget. 2017 Dec 8;9(1):512-523
pubmed: 29416632
Genome Biol. 2021 May 10;22(1):129
pubmed: 33966634
Mol Cell Biol. 2005 May;25(9):3575-82
pubmed: 15831463
Nucleic Acids Res. 2020 Jan 24;48(2):646-664
pubmed: 31754707
Nucleic Acids Res. 2018 Feb 28;46(4):1756-1776
pubmed: 29240919
Cancer Lett. 2020 Aug 28;486:46-57
pubmed: 32445837
J Chem Inf Model. 2010 Apr 26;50(4):662-76
pubmed: 20225870
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
Mol Cancer Ther. 2017 Dec;16(12):2656-2667
pubmed: 28878027
Cell Death Dis. 2019 Feb 21;10(3):177
pubmed: 30792387
Nucleic Acids Res. 2011 May;39(10):4464-74
pubmed: 21278418
Nucleic Acids Res. 2008 Feb;36(3):915-28
pubmed: 18086704
Nucleic Acids Res. 2012 Jul;40(12):5378-88
pubmed: 22396528
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):261-273
pubmed: 29879430
Epigenetics Chromatin. 2015 Sep 16;8:29
pubmed: 26380582

Auteurs

Martina Minisini (M)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Eros Di Giorgio (E)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Emanuela Kerschbamer (E)

Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck. Via Galvani 31, 39100 Bolzano, Italy.

Emiliano Dalla (E)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Massimo Faggiani (M)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Elisa Franforte (E)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Franz-Josef Meyer-Almes (FJ)

Department of Chemical Engineering and Biotechnology, University of Applied Science, Haardtring 100, 64295 Darmstadt, Germany.

Rino Ragno (R)

Rome Center for Molecular Design, Department of Chemistry and Technology of Drugs, "Sapienza" University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Lorenzo Antonini (L)

Rome Center for Molecular Design, Department of Chemistry and Technology of Drugs, "Sapienza" University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Antonello Mai (A)

Department of Chemistry and Technology of Drugs, "Sapienza" University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Francesco Fiorentino (F)

Department of Chemistry and Technology of Drugs, "Sapienza" University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Dante Rotili (D)

Department of Chemistry and Technology of Drugs, "Sapienza" University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Monica Chinellato (M)

Department of Biology, University of Padova, Via U. Bassi, 58/B, 35121 Padova, Italy.

Stefano Perin (S)

Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, 30172 Mestre, Italy.
European Centre for Living Technology (ECLT), Dorsoduro 3911, Calle Crosera, 30123 Venice, Italy.

Laura Cendron (L)

Department of Biology, University of Padova, Via U. Bassi, 58/B, 35121 Padova, Italy.

Christian X Weichenberger (CX)

Institute for Biomedicine, Eurac Research, Affiliated Institute of the University of Lübeck. Via Galvani 31, 39100 Bolzano, Italy.

Alessandro Angelini (A)

Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, Via Torino 155, 30172 Mestre, Italy.
European Centre for Living Technology (ECLT), Dorsoduro 3911, Calle Crosera, 30123 Venice, Italy.

Claudio Brancolini (C)

Department of Medicine, Università degli Studi di Udine. P.le Kolbe 4, 33100 Udine Italy.

Articles similaires

Arabidopsis Arabidopsis Proteins Osmotic Pressure Cytoplasm RNA, Messenger
Animals Lung India Sheep Transcriptome

Revealing molecular mechanisms of early-onset tongue cancer by spatial transcriptomics.

Marina R Patysheva, Elena S Kolegova, Anna A Khozyainova et al.
1.00
Humans Tongue Neoplasms Male Adult Middle Aged
Animals Astrocytes Amyloid beta-Protein Precursor Mice Mice, Transgenic

Classifications MeSH